Evidence map›Paper›PMID 42459712›Full record

ArticleEuropean heart journal. Imaging methods and practice2026

Prognostic value of left ventricular hypertrophy assessed with

Jonathan Sigfridsson, Patrik Svanström, Tanja Kero, Hendrik J Harms, Jonny Nordström, Mark Lubberink, Jens Sörensen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European heart journal. Imaging methods and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jonathan SigfridssonMolecular Imaging and Medical Physics, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.ORCID https://orcid.org/0000-0001-8382-3624
Patrik SvanströmMolecular Imaging and Medical Physics, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Tanja KeroMolecular Imaging and Medical Physics, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.ORCID https://orcid.org/0009-0008-2002-8699
Hendrik J HarmsMolecular Imaging and Medical Physics, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Jonny NordströmMolecular Imaging and Medical Physics, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Mark LubberinkMolecular Imaging and Medical Physics, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Jens SörensenMolecular Imaging and Medical Physics, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.ORCID https://orcid.org/0000-0002-3121-0938

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: Left ventricular (LV) hypertrophy is associated with adverse cardiac outcomes. LV mass index (LVMi) and interventricular septal wall thickness (WT) can be derived from Methods and results: We retrospectively included 783 consecutive patients referred for rest-stress PET. LVMi and WT were determined on non-ECG-gated resting Conclusion: PET LV hypertrophy metrics can be robustly quantified from routine

Indexed as

cardiac PETcoronary artery diseaseheart failureleft ventricular hypertrophyprognosis

Identifiers

PMID42459712
PMCPMC13372030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.